4 Biotech stocks benefiting from OMICRON variant multi bagger potential PSTI, CRTX, ARCT, IBRX

PSTI
ARDS trial: https://www.pluristem.com/wp-content/uploads/2021/07/PSTI-COVID-19-update-July-2021-FINAL-FOR-RELEASE.pdf
DD article: https://www.shovel-stocks.com/post/pluristem-investment-thesis
CRTX
COR803: https://www.cortexyme.com/cortexyme-announces-lead-3clpro-inhibitor-for-the-treatment-of-coronavirus-infection/
DD article: https://www.shovel-stocks.com/post/cortexyme-crtx-update-8-reasons-i-bought-the-dip
ARCT
Pipeline: https://arcturusrx.com/mrna-medicines-pipeline/#lunarCovid
DD Video: https://www.youtube.com/watch?v=Bff1-YelxAw
IBRX
Vaccine: https://ir.immunitybio.com/news-releases/news-release-details/immunitybio-expands-vaccine-program-accelerate-use-mix-and-match?field_nir_news_date_value[min]=
DD article: https://www.shovel-stocks.com/post/immunitybio-ibrx-update-major-disconnect-between-value-price